Neurocrine Bioscience buy Truist Financial Co.
Start price
13.07.26
/
50%
€154.55
Target price
13.07.27
€175.50
Performance (%)
-1.71%
Price
13:57
€151.90
Summary
This prediction is currently active. With a performance of -1.71%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 13.07.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.71% |
| iShares Core DAX® | -0.097% |
| iShares Nasdaq 100 | 0.585% |
| iShares Nikkei 225® | -0.055% |
| iShares S&P 500 | 0.939% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Truist Financial Corporation from $155.00 to $200.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€127.50
07.05.26
07.05.26
€131.84
07.05.27
07.05.27
19.14%
13:57
13:57
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
40.84%
13:57
13:57
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
30.11%
13:57
13:57
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
27.27%
13:57
13:57